Exploration of a Novel Prognostic Prediction Model for Liver Cirrhosis

Recruiting Observational Study
Cirrhosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Juan Kang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The liver, a key organ for metabolism and synthesis, is involved in protein, fat, and carbohydrate metabolism, as well as energy production. Hepatic injury and functional decline can lead to metabolic abnormalities in these three major nutrients, as well as in vitamins and trace elements. Malnutrition, one of the most common complications in cirrhosis patients, has a broader impact than traditiona…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Participants must meet all of the following criteria to be eligible for this study. 1. Willingness and ability to sign the informed consent form. 2. Male or female, aged 18 to 75 years. 3. A diagnosis of liver cirrhosis that meets the reference criteria of the Chinese Society o…
Contacts

juan Kang, M.D.

+8613996112052

68368892@qq.com

CONTACT